💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Cytokinetics, Incorporated (CYTK)
« Back to company indexCYTK Chatter Timeline
Stock Ticker for CYTK
Most Active Tweeters for CYTK
| User | Tweets |
|---|---|
| @Allstocknews | 13 |
| @FlashAlert_me | 9 |
| @Tickeron | 6 |
| @fintel_io | 5 |
| @EdgarInsider | 4 |
Recent Tweets for CYTK
 |
@newsfilterio Form 10-Q (quarterly report [sections 13 or 15(d)]) filed with the SEC $CYTK https://t.co/NI2RlaToNi May 8th 2021, 7:05pm |
|
@newsfilterio $84,550.00 of shares sold by Blum Robert I (President & CEO), reported in a new form 4 filed with the SEC $CYTK https://t.co/sWLDu5srcd May 8th 2021, 3:05pm |
 |
@InsiderAlerts4U $CYTK: New Insider Filing on CYTOKINETICS INC's President & CEO ROBERT I BLUM: https://t.co/Qo8eVbfKyr May 8th 2021, 7:05am |
 |
@StkOptionCoach_ RT @StockTradersHQ: $CYTK has reached our 40% profit target today. See chart for buy/sell points. We still profit even in a down market h… May 8th 2021, 5:05am |
|
@StkOptionCoach_ RT @StockTradersHQ: Sold $CYTK for a 25% profit in 24 hours!!! 1% per hour. If I could only do that all year!! LOL May 8th 2021, 5:05am |
 |
@fintel_io Insider Robert I Blum reports selling 5,000 shares of $CYTK for a total cost of $116,041.00 https://t.co/1dXERTmT8A May 7th 2021, 10:05pm |
 |
@FlashAlert_me $CYTK [15s. delayed] filed SEC form 4: President & CEO Blum Robert I: Disposed 5,000 of Common Stock at price $23.… https://t.co/CZcyDiOFnG May 7th 2021, 10:05pm |
 |
@Allstocknews $CYTK New Form 10-Q for Cytokinetics Inc From our Stock News Alerts App May 7th 2021, 9:05pm |
 |
@EarningsAlley Cytokinetics, Incorporated $CYTK held an earnings call on 5/6/2021. Here are the highlights: May 7th 2021, 8:05am |
 |
@ERCalendar Upcoming Earnings Report: $CYTK Cytokinetics Reporting on 05/06/2021 at 4:00 PM? Get Free Daily ER Calendar Sent To… https://t.co/cN4NvbvGBi May 6th 2021, 9:05pm |
 |
@MarcJacksonLA $CYTK Cytokinetics Announces Start of Open-Label Extension Study for Patients Completing REDWOOD-HCM | BioSpace… https://t.co/IPelFQtSV3 May 6th 2021, 8:05pm |
 |
@Estimize $CYTK misses the Estimize EPS Consensus by 18c and the Estimize Revenue Consensus by $0.23M. Reports FQ1 earnings o… https://t.co/yjY4u5KMrx May 6th 2021, 8:05pm |
|
@Estimize $CYTK reports FQ1 earnings of -66c EPS and $6.55M Revs - https://t.co/1NZjRaEyGr May 6th 2021, 8:05pm |
|
@Allstocknews $CYTK Cytokinetics Reports First Quarter 2021 Financial Results From our Stock News Alerts App May 6th 2021, 8:05pm |
|
@fintel_io $CYTK / Cytokinetics files form 8-K - Financial Statements and Exhibits, Results of Operations and Financial Condit… https://t.co/1tLnIyyHLV May 6th 2021, 8:05pm |
 |
@Cytokinetics $CYTK Investors: Today we reported our first quarter 2021 financial results. More details will be provided by our s… https://t.co/RhPwZ3EJLS May 6th 2021, 8:05pm |
|
@FlashAlert_me $CYTK [15s. delayed]: Issued Press Release on May 06, 16:00:00: Cytokinetics Reports First Quarter 2021 Financial R… https://t.co/wX7QJDBpK3 May 6th 2021, 8:05pm |
 |
@EdgarInsider New Form 8-K [Press/News Current Report] entry filed by $CYTK CYTOKINETICS INC https://t.co/oKamtQOS1E May 6th 2021, 8:05pm |
|
@FlashAlert_me $CYTK [15s. delayed] filed form 8-K on May 06, 16:00:25 https://t.co/Df120PQ0tv May 6th 2021, 8:05pm |
|
@Allstocknews $CYTK Cytokinetics Reports First Quarter 2021 Financial Results From our Stock News Alerts App May 6th 2021, 8:05pm |
 |
@StockPods $CYTK Earnings Call Today: 4:30 PM EST Webcast: https://t.co/iQ3o4ir4Lx Signup for the StockPods BETA now: https://t.co/Vma4E2hQ99 May 6th 2021, 7:05pm |
 |
@AccesswireNews $CYTK Cytokinetics, Inc. to Host Earnings Call https://t.co/hW4l3DQ1Ll May 6th 2021, 6:05pm |
 |
@Tickeron $CYTK reports Earnings today. $CYTK in Downtrend: RSI indicator exits overbought zone. View odds for this and other… https://t.co/loMZoveyXE May 6th 2021, 5:05pm |
 |
@Gambiste1 RT @SmallCapsDaily: $CYTK Cytokinetics Announces Start of Open-Label Extension Study for Patients Completing REDWOOD-HCM GlobeNewswire http… May 6th 2021, 4:05pm |
 |
@SmallCapsDaily $CYTK Cytokinetics Announces Start of Open-Label Extension Study for Patients Completing REDWOOD-HCM GlobeNewswire… https://t.co/ds4bylhmdc May 6th 2021, 3:05pm |
|
@Estimize $CYTK reports after the close, Estimize Consensus +0.25 EPS and +0.44M Revs compared to WS - https://t.co/6LVaVybpSt May 6th 2021, 3:05pm |
 |
@sbwcws Cytokinetics announces start of OLE study for patients completing REDWOOD-HCM $CYTK May 6th 2021, 12:05pm |
 |
@otcdynamics $CYTK Cytokinetics Announces Start of Open-Label Extension Study for Patients Completing REDWOOD-HCM https://t.co/IprFUBtrIn May 6th 2021, 11:05am |
|
@Allstocknews $CYTK Cytokinetics Announces Start of Open-Label Extension Study for Patients Completing REDWOOD-HCM From our Stock News Alerts App May 6th 2021, 11:05am |
|
@EdgarInsider Filing for 8-K [Press/News Current Report] has been made with the SEC: $CYTK CYTOKINETICS INC https://t.co/xVFBQDQjhp May 6th 2021, 11:05am |
|
@FlashAlert_me $CYTK [15s. delayed]: Issued Press Release on May 06, 07:30:00: Cytokinetics Announces Start of Open-Label Extensio… https://t.co/QBg0WgWmDC May 6th 2021, 11:05am |
 |
@kevinjaybe $CYTK Cytokinetics Announces Start Of Open-Label Extension Study For Patients Completing Redwood-Hcm https://t.co/Ri3AZzZxls May 6th 2021, 11:05am |
|
@FlashAlert_me $CYTK [15s. delayed] filed form 8-K on May 06, 07:30:14: Item8.01: Other Material Events https://t.co/cTRkLH7osA May 6th 2021, 11:05am |
|
@Allstocknews $CYTK Cytokinetics Announces Start of Open-Label Extension Study for Patients Completing REDWOOD-HCM From our Stock News Alerts App May 6th 2021, 11:05am |
 |
@stock_titan $CYTK Cytokinetics Announces Start of Open-Label Extension Study for Patients Completing REDWOOD-HCM https://t.co/h2OqdbYQuO May 6th 2021, 11:05am |
|
@Tickeron Cytokinetics Inc to report earnings on July 29, 2021. Earnings per share (EPS) estimate: $-0.45 $CYTK #Cytokinetics… https://t.co/Zl9lZ97fdm May 5th 2021, 10:05pm |
|
@Allstocknews $CYTK Cytokinetics to Hold Annual Meeting of Stockholders From our Stock News Alerts App May 5th 2021, 8:05pm |
|
@Cytokinetics $CYTK Investors: Today we announced that we will be holding our annual shareholder meeting on Wednesday, May 12, at… https://t.co/nKH0v4carw May 5th 2021, 8:05pm |
|
@kevinjaybe $CYTK Cytokinetics To Hold Annual Meeting Of Stockholders https://t.co/wQvHD2OU7z May 5th 2021, 8:05pm |
|
@FlashAlert_me $CYTK [15s. delayed]: Issued Press Release on May 05, 16:00:00: Cytokinetics to Hold Annual Meeting of Stockholders https://t.co/RzFK5BMJiW May 5th 2021, 8:05pm |
|
@Allstocknews $CYTK Cytokinetics to Hold Annual Meeting of Stockholders From our Stock News Alerts App May 5th 2021, 8:05pm |
|
@stock_titan $CYTK Cytokinetics to Hold Annual Meeting of Stockholders https://t.co/kZEQ2D9baJ May 5th 2021, 8:05pm |
 |
@bthefirsttoknow $CYTK: Cytokinetics to Hold Annual Meeting of Stockholders https://t.co/0G8iZxtPIT May 5th 2021, 8:05pm |
 |
@TradeWithAlerts Nice Print for $CYTK - Amount: $3,200,519.00 - to learn more, SIGNUP https://t.co/JWvlYbdLod or get a training https://t.co/0L4k6hWHAt! May 5th 2021, 7:05pm |
|
@TradeWithAlerts Nice Print for $CYTK - Amount: $3,604,995.60 - to learn more, SIGNUP https://t.co/JWvlYbdLod or get a training https://t.co/0L4k6hWHAt! May 4th 2021, 4:05pm |
|
@SmallCapsDaily $CYTK Cytokinetics Announces Cohort 3 of REDWOOD-HCM is Open to Enrollment GlobeNewswire https://t.co/3DhNjzYsSV… https://t.co/nvvxfBlK0T May 4th 2021, 3:05pm |
|
@MarcJacksonLA $CYTK Cytokinetics Announces Cohort 3 of REDWOOD-HCM is Open to EnrollmentNext Cohort to Enroll Patients on Backgro… https://t.co/hdqnYrcZMl May 4th 2021, 2:05pm |
|
@otcdynamics $CYTK Cytokinetics Announces Cohort 3 of REDWOOD-HCM is Open to Enrollment https://t.co/ADqWTOKsY2 May 4th 2021, 11:05am |
|
@Allstocknews $CYTK Cytokinetics Announces Cohort 3 of REDWOOD-HCM is Open to Enrollment From our Stock News Alerts App May 4th 2021, 11:05am |
|
@Allstocknews $CYTK Cytokinetics Announces Cohort 3 of REDWOOD-HCM is Open to Enrollment From our Stock News Alerts App May 4th 2021, 11:05am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
Get the DrugPatentWatch Daily Briefing
Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
Want insights into the biggest revenue-changing events?
Billions of dollars in sales can evaporate overnight as drug patents expire and competitors enter the market.
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
➤ Free Trial
